Schedule of Earnings Per Share, Basic and Diluted |
|
|
For the Three
Months Ended
February 28,
2021
|
|
For the Nine
Months Ended
February 28,
2021
|
Numerator: |
|
|
|
|
Net income |
$ |
1,264,998 |
|
2,088,044 |
Effect of dilutive securities |
|
431,163 |
|
606,519 |
|
|
|
|
|
Diluted net income |
$ |
1,696,161 |
$ |
2,694,563 |
|
|
|
|
|
Denominator: |
|
|
|
|
Weighted average common shares outstanding basic |
|
357,891,040 |
|
230,663,175 |
|
|
|
|
|
Dilutive securities (a): |
|
|
|
|
Series A Preferred |
|
1,177,041,100 |
|
1,177,041,100 |
Series B Preferred |
|
5,499,034,800 |
|
5,499,034,800 |
Convertible notes |
|
1,809,848,927 |
|
1,809,848,927 |
Warrants |
|
1,132,733,563 |
|
1,132,733,563 |
|
|
|
|
|
Weighted average common shares outstanding and assumed conversion diluted |
|
9,976,549,430 |
|
9,849,321,565 |
|
|
|
|
|
Basic net income per common share |
$ |
0.00 |
$ |
0.01 |
|
|
|
|
|
Diluted net income per common share |
$ |
0.00 |
$ |
0.00 |
|
|
|
|
|
(a) - Anti-dilutive securities excluded: |
|
- |
|
- |
|